Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RCKTROCKET PHARMACEUTICALS, INC.

Nasdaq · CIK 0001281895
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts353

Identity from submissions API

NameROCKET PHARMACEUTICALS, INC.
CIK0001281895
TickersRCKT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone646-440-9100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • INOTEK PHARMACEUTICALS CORP (2004-02-25T00:00:00.000Z → 2017-12-22T00:00:00.000Z)
Business address
350 FIFTH AVENUE
SUITE 7530
NEW YORK
NY
10118
NY
Mailing address
350 FIFTH AVENUE
SUITE 7530
NEW YORK
NY
10118
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

982 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 FORM 4 0001140361-26-045110 6506
2026-11-20 4 FORM 4 0001140361-26-045108 5150
2026-11-18 144 xsl144X01/primary_doc.xml 0001959173-26-008145 001-36829 261570075 33 5783
2026-11-18 144 xsl144X01/primary_doc.xml 0001959173-26-008141 001-36829 261569891 33 6897
2026-11-17 4 FORM 4 0001140361-26-044546 6506
2026-11-17 4 FORM 4 0001140361-26-044544 5092
2026-11-13 144 xsl144X01/primary_doc.xml 0001959173-26-008010 001-36829 261552971 33 5809
2026-11-13 144 xsl144X01/primary_doc.xml 0001959173-26-008008 001-36829 261552038 33 6901
2026-11-12 4 FORM 4 0001140361-26-043480 5222
2026-11-12 8-K 8-K 2.02,9.01 0001140361-26-043434 001-36829 261547183 34 228612 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458320 001-36829 261546842 34 18289914 1 1
2026-11-09 4 FORM 4 0001140361-26-042784 5094
2026-11-09 144 xsl144X01/primary_doc.xml 0001959173-26-007868 001-36829 261535627 33 5223
2026-11-09 144 xsl144X01/primary_doc.xml 0001959173-26-007867 001-36829 261535620 33 5186
2026-11-05 144 xsl144X01/primary_doc.xml 0001959173-26-007789 001-36829 261526768 33 6322
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001123 005-88750 261507072 34 7591
2026-10-06 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001140361-26-038818 001-36829 261444879 34 10921094 1 1
2026-09-15 4 FORM 4 0001140361-26-036688 4953
2026-09-15 144 xsl144X01/primary_doc.xml 0001959173-26-006989 001-36829 261381440 33 6356
2026-09-15 8-K 8-K 7.01,9.01 0001140361-26-036563 001-36829 261379120 34 184305 1 1
2026-09-14 144 xsl144X01/primary_doc.xml 0001959173-26-006938 001-36829 261377142 33 5778
2026-09-11 144 xsl144X01/primary_doc.xml 0001959173-26-006908 001-36829 261375050 33 5739
2026-09-11 144 xsl144X01/primary_doc.xml 0001959173-26-006907 001-36829 261375034 33 5199
2026-09-02 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000844 001-36829 261355145 34 3115
2026-08-27 8-K 8-K 5.02 0001140361-26-034689 001-36829 261330176 34 173726 1 1
2026-08-20 4 xslF345X06/form4.xml 0001140361-26-033915 4931
2026-08-20 4 xslF345X06/form4.xml 0001140361-26-033913 6345
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006169 001-36829 261290402 33 6367
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006168 001-36829 261290395 33 5733
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006166 001-36829 261290372 33 5733
2026-08-17 4 FORM 4 0001140361-26-033417 6365
2026-08-17 4 FORM 4 0001140361-26-033413 4952
2026-08-13 4 FORM 4 0001140361-26-032818 5051
2026-08-13 4 FORM 4 0001140361-26-032816 5081
2026-08-13 144 xsl144X01/primary_doc.xml 0001959173-26-005995 001-36829 261273072 33 5739
2026-08-13 144 xsl144X01/primary_doc.xml 0001959173-26-005994 001-36829 261272836 33 6368
2026-08-11 144 xsl144X01/primary_doc.xml 0001959173-26-005892 001-36829 261262848 33 4627
2026-08-11 144 xsl144X01/primary_doc.xml 0001959173-26-005891 001-36829 261262807 33 4601
2026-08-10 8-K 8-K 2.02,9.01 0001140361-26-032028 001-36829 261258671 34 310949 1 1
2026-08-10 10-Q 10-Q 0001193125-26-342348 001-36829 261258371 34 20591061 1 1
2026-08-05 4 xslF345X06/form4.xml 0001140361-26-031473 7504
2026-08-05 4 xslF345X06/form4.xml 0001140361-26-031471 6012
2026-08-03 8-K 8-K 7.01,9.01 0001140361-26-030568 001-36829 261230491 34 186059 1 1
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001008 005-88750 261226760 34 7489
2026-07-14 S-8 S-8 0001140361-26-028436 333-297451 261174337 33 234917 1 1
2026-07-08 3 FORM 3 0001140361-26-027999 19693
2026-07-07 144 xsl144X01/primary_doc.xml 0001959173-26-005144 001-36829 261159164 33 4614
2026-07-06 4 FORM 4 0001140361-26-027681 8215
2026-07-06 4 FORM 4 0001140361-26-027680 7068
2026-07-06 4 FORM 4 0001140361-26-027679 7071
2026-07-06 4 FORM 4 0001140361-26-027678 7050
2026-07-06 4 FORM 4 0001140361-26-027677 7776
2026-07-06 4 FORM 4 0001140361-26-027676 7040
2026-06-30 8-K 8-K 5.02 0001140361-26-026982 001-36829 261141600 34 157186 1 1
2026-06-12 8-K 8-K 2.01,7.01,9.01 0001140361-26-024997 001-36829 261084900 34 182189 1 1
2026-05-28 SC TO-I/A SC TO-I/A 0001140361-26-023174 005-88750 261037771 34 17381
2026-05-28 4 FORM 4 0001140361-26-023153 43061
2026-05-26 4 FORM 4 0001140361-26-022894 10794
2026-05-21 4 FORM 4 0001140361-26-022447 6365
2026-05-21 4 FORM 4 0001140361-26-022446 4951
2026-05-21 4 FORM 4 0001140361-26-022445 5102
2026-05-21 144 xsl144X01/primary_doc.xml 0001959173-26-003871 001-36829 261008134 33 5639
2026-05-21 8-K 8-K 5.07 0001140361-26-022311 001-36829 261005794 34 170835 1 1
2026-05-19 144 xsl144X01/primary_doc.xml 0001959173-26-003774 001-36829 26998244 33 5208
2026-05-19 144 xsl144X01/primary_doc.xml 0001959173-26-003773 001-36829 26998217 33 5192
2026-05-19 144 xsl144X01/primary_doc.xml 0001959173-26-003766 001-36829 26998160 33 5152
2026-05-14 4 xslF345X06/form4.xml 0001140361-26-021321 4931
2026-05-14 4 xslF345X06/form4.xml 0001140361-26-021315 6344
2026-05-14 4 xslF345X06/form4.xml 0001140361-26-021305 5081
2026-05-13 144 xsl144X01/primary_doc.xml 0001959173-26-003570 001-36829 26972818 33 5740
2026-05-13 144 xsl144X01/primary_doc.xml 0001959173-26-003569 001-36829 26972800 33 5789
2026-05-13 144 xsl144X01/primary_doc.xml 0001959173-26-003566 001-36829 26972783 33 5763
2026-05-11 4 FORM 4 0001140361-26-020649 5081
2026-05-07 8-K 8-K 2.02,9.01 0001140361-26-019573 001-36829 26954434 34 307682 1 1
2026-05-07 10-Q 10-Q 0001193125-26-211873 001-36829 26953155 34 18093802 1 1
2026-05-07 144 xsl144X01/primary_doc.xml 0001959173-26-003384 001-36829 26952536 33 4614
2026-04-28 8-K 8-K 1.01,7.01,9.01 0001140361-26-017275 001-36829 26903153 34 188751 1 1
2026-04-27 SC TO-I SC TO-I 0001140361-26-016865 005-88750 26897111 34 19880884 1 1
2026-04-06 ARS ARS 0001140361-26-013342 001-36829 26841326 34 1789142
2026-04-06 DEFA14A DEFA14A 0001140361-26-013340 001-36829 26841304 34 4082783
2026-04-06 DEF 14A DEF 14A 0001140361-26-013335 001-36829 26841222 34 5972193 1 1
2026-04-03 SC TO-C SC TO-C 0001140361-26-013112 005-88750 26836867 34 99715
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002213 005-88750 26804338 34 7285
2026-03-27 8-K 8-K 7.01,9.01 0001140361-26-011573 001-36829 26801075 34 205157 1 1
2026-03-25 PRE 14A PRE 14A 0001140361-26-010967 001-36829 26788072 34 5969483 1 1
2026-03-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000767 333-293925 26741430 33 1863
2026-03-10 8-K 8-K 1.01,1.02,9.01 0001140361-26-008853 001-36829 26740583 34 636187 1 1
2026-03-10 424B5 424B5 0001140361-26-008849 333-293925 26740544 33 411763
2026-03-06 CORRESP filename1.htm 0001140361-26-008290 33449
2026-03-06 UPLOAD filename1.pdf 0000000000-26-002361 333-293925 40125
2026-03-02 S-3 S-3 0001140361-26-007341 333-293925 26707879 33 1224497 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001140361-26-006981 001-36829 26688578 34 279631 1 1
2026-02-26 10-K 10-K 0001193125-26-076551 001-36829 26687829 34 17539178 1 1
2026-02-20 4 FORM 4 0001140361-26-006330 4965
2026-02-20 4 FORM 4 0001140361-26-006326 6227
2026-02-20 4 FORM 4 0001140361-26-006317 4814
2026-02-18 4 FORM 4 0001140361-26-006047 4815
2026-02-18 4 FORM 4 0001140361-26-006045 4965
2026-02-18 4 FORM 4 0001140361-26-006043 6228
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001181 001-36829 26649700 33 5768
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001176 001-36829 26649487 33 5735
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001175 001-36829 26649476 33 5788
2026-02-13 144 xsl144X01/primary_doc.xml 0001959173-26-001000 001-36829 26633697 33 5162
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-26-000137 005-88750 26632834 34 11660
2026-02-13 4 FORM 4 0001140361-26-005412 8712
2026-02-13 4 FORM 4 0001140361-26-005411 7354
2026-02-13 4 FORM 4 0001140361-26-005410 7299
2026-02-13 4 FORM 4 0001140361-26-005409 7380
2026-02-13 4 FORM 4 0001140361-26-005408 7388
2026-02-13 4 FORM 4 0001140361-26-005407 7428
2026-02-13 144 xsl144X01/primary_doc.xml 0001959173-26-000994 001-36829 26632225 33 5200
2026-02-13 144 xsl144X01/primary_doc.xml 0001959173-26-000992 001-36829 26632215 33 5191
2026-02-13 144 xsl144X01/primary_doc.xml 0001959173-26-000986 001-36829 26632059 33 5191
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000302 005-88750 26582653 34 7122
2026-01-06 4 FORM 4 0001140361-26-000378 4595
2025-11-20 4 FORM 4 0001140361-25-042856 4674
2025-11-20 4 FORM 4 0001140361-25-042857 4704
2025-11-20 4 FORM 4 0001140361-25-042855 6007
2025-11-20 4 FORM 4 0001140361-25-042854 4553
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007115 001-36829 251494412 33 5775
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007109 001-36829 251494204 33 4625
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007107 001-36829 251494113 33 6359
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007106 001-36829 251494112 33 5737
2025-11-10 4 FORM 4 0001140361-25-041393 4749
2025-11-06 10-Q 10-Q 0001193125-25-269474 001-36829 251458229 34 21496895 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001140361-25-040774 001-36829 251458135 34 281494 1 1
2025-10-16 4 FORM 4 0001140361-25-038302 8905
2025-10-14 144 xsl144X01/primary_doc.xml 0001959173-25-006434 001-36829 251390853 33 18024
2025-10-14 8-K 8-K 8.01,9.01 0001140361-25-038030 001-36829 251389590 34 188269 1 1
2025-10-08 4 FORM 4 0001140361-25-037683 9420
2025-10-03 4 FORM 4 0001140361-25-037275 6316
2025-10-03 3 FORM 3 0001140361-25-037273 18867
2025-10-03 8-K 8-K 5.02 0001140361-25-037237 001-36829 251374389 34 150597 1 1
2025-10-03 8-K 8-K 8.01 0001140361-25-037163 001-36829 251372069 34 157496 1 1
2025-09-29 8-K 8-K 5.02 0001140361-25-036556 001-36829 251357335 34 154703 1 1
2025-09-23 4 xslF345X05/form4-09232025_080918.xml 0001231919-25-000232 24678
2025-09-22 3 FORM 3 0001140361-25-035745 18406
2025-09-17 8-K 8-K 1.01,9.01 0001140361-25-035251 001-36829 251320189 34 336626 1 1
2025-09-09 4 FORM 4 0001140361-25-034431 5016
2025-09-09 4 FORM 4 0001140361-25-034422 4866
2025-09-09 4 FORM 4 0001140361-25-034420 4986
2025-08-27 4 FORM 4 0001140361-25-033017 4596
2025-08-25 8-K 8-K 5.02 0001140361-25-032502 001-36829 251250903 34 153606 1 1
2025-08-20 4 FORM 4 0001140361-25-032092 6361
2025-08-20 4 FORM 4 0001140361-25-032091 6333
2025-08-20 4 FORM 4 0001140361-25-032090 6212
2025-08-20 4 FORM 4 0001140361-25-032089 6221
2025-08-20 8-K 8-K 8.01,9.01 0001140361-25-032012 001-36829 251233836 34 190163 1 1
2025-08-19 144 xsl144X01/primary_doc.xml 0001959173-25-005347 001-36829 251231462 33 6317
2025-08-19 144 xsl144X01/primary_doc.xml 0001959173-25-005345 001-36829 251231426 33 6346
2025-08-19 144 xsl144X01/primary_doc.xml 0001959173-25-005344 001-36829 251231418 33 6346
2025-08-18 4 FORM 4 0001140361-25-031762 4895
2025-08-18 4 FORM 4 0001140361-25-031761 4924
2025-08-18 4 FORM 4 0001140361-25-031760 4774
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005293 001-36829 251227678 33 5732
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005284 001-36829 251227631 33 5767
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005283 001-36829 251227627 33 5773
2025-08-14 144 xsl144X01/primary_doc.xml 0001959173-25-005206 001-36829 251221458 33 5767
2025-08-14 144 xsl144X01/primary_doc.xml 0001959173-25-005198 001-36829 251221413 33 5586
2025-08-14 144 xsl144X01/primary_doc.xml 0001959173-25-005196 001-36829 251221391 33 5779
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-023726 005-88750 251214433 34 11759
2025-08-07 10-Q 10-Q 0000950170-25-104996 001-36829 251193951 34 21097745 1 1
2025-08-07 8-K 8-K 2.02,5.02,9.01 0001140361-25-029582 001-36829 251193776 34 299465 1 1
2025-08-06 4 FORM 4 0001140361-25-029144 7292
2025-08-04 3 FORM 3 0001140361-25-028612 20810
2025-07-24 8-K 8-K 8.01,9.01 0001140361-25-027032 001-36829 251144505 34 190695 1 1
2025-07-23 8-K 8-K 2.05 0001140361-25-026946 001-36829 251143414 34 153119 1 1
2025-07-18 4 FORM 4 0001140361-25-026411 4610
2025-07-18 4 FORM 4 0001140361-25-026410 6151
2025-07-18 4 FORM 4 0001140361-25-026409 4817
2025-07-18 4 FORM 4 0001140361-25-026412 7513
2025-07-18 4 FORM 4 0001140361-25-026408 8359
2025-07-18 4 FORM 4 0001140361-25-026407 4608
2025-07-18 4 FORM 4 0001140361-25-026406 4639
2025-07-18 4 FORM 4 0001140361-25-026405 4643
2025-07-18 4 FORM 4 0001140361-25-026404 5377
2025-07-17 8-K 8-K 8.01,9.01 0001140361-25-026132 001-36829 251128826 34 186942 1 1
2025-07-11 8-K 8-K 5.02 0001140361-25-025673 001-36829 251119399 34 160729 1 1
2025-07-08 4 FORM 4 0001140361-25-025244 4782
2025-07-03 144 xsl144X01/primary_doc.xml 0001959173-25-004468 001-36829 251105297 33 5131
2025-06-18 8-K 8-K 5.07 0001140361-25-022996 001-36829 251057579 34 169758 1 1
2025-06-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000254 005-88750 251028609 34 15437
2025-05-27 8-K 8-K 7.01,9.01 0001140361-25-020409 001-36829 25984210 34 209884 1 1
2025-05-22 4 FORM 4 0001140361-25-020163 4922
2025-05-22 4 FORM 4 0001140361-25-020162 4892
2025-05-22 4 FORM 4 0001140361-25-020161 6499
2025-05-22 4 FORM 4 0001140361-25-020160 6226
2025-05-22 4 FORM 4 0001140361-25-020159 4771
2025-05-20 4 FORM 4 0001140361-25-019902 4922
2025-05-20 4 FORM 4 0001140361-25-019901 6500
2025-05-20 4 FORM 4 0001140361-25-019900 4893
2025-05-20 4 FORM 4 0001140361-25-019899 6226
2025-05-20 4 FORM 4 0001140361-25-019898 4771
2025-05-20 144 xsl144X01/primary_doc.xml 0001959173-25-003370 001-36829 25968306 33 5732
2025-05-20 144 xsl144X01/primary_doc.xml 0001959173-25-003368 001-36829 25968272 33 6344
2025-05-20 144 xsl144X01/primary_doc.xml 0001959173-25-003366 001-36829 25968258 33 5774
2025-05-20 144 xsl144X01/primary_doc.xml 0001959173-25-003364 001-36829 25968245 33 5791
2025-05-20 144 xsl144X01/primary_doc.xml 0001959173-25-003363 001-36829 25968241 33 5736
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003292 001-36829 25959377 33 5188
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003291 001-36829 25959255 33 5211
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003289 001-36829 25959203 33 5153
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003273 001-36829 25958690 33 5768
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003266 001-36829 25958615 33 5152
2025-05-15 8-K 8-K 7.01,8.01,9.01 0001140361-25-019326 001-36829 25955024 34 5011215 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001140361-25-017958 001-36829 25926233 34 262922 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066898 001-36829 25925838 34 20339088 1 1
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000154 005-88750 25919710 34 17291
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000151 005-88750 25919695 34 17294
2025-04-30 ARS ARS 0001140361-25-016664 001-36829 25895561 34 2134079
2025-04-30 DEFA14A DEFA14A 0001140361-25-016659 001-36829 25895486 34 303190
2025-04-30 DEF 14A DEF 14A 0001140361-25-016656 001-36829 25895399 34 7031515 1 1
2025-04-29 8-K 8-K 5.02 0001140361-25-016338 001-36829 25888047 34 161441 1 1
2025-04-24 4 FORM 4 0001140361-25-015426 4922
2025-04-24 4 FORM 4 0001140361-25-015425 5077
2025-04-22 3 FORM 3 0001140361-25-014900 10358
2025-04-22 144 xsl144X01/primary_doc.xml 0001959173-25-002667 001-36829 25857393 33 5762
2025-04-14 4 FORM 4 0001140361-25-013804 5785
2025-04-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-053778 005-88750 25836711 34 48006
2025-04-10 4 FORM 4 0001140361-25-013253 6734
2025-04-09 144 xsl144X01/primary_doc.xml 0001959173-25-002558 001-36829 25825051 33 5763
2025-04-08 4 FORM 4 0001140361-25-012826 4781
2025-04-07 8-K 8-K 5.02 0001140361-25-012621 001-36829 25819094 34 169200 1 1
2025-04-04 144 xsl144X01/primary_doc.xml 0001959173-25-002516 001-36829 25813594 33 4541
2025-03-03 S-8 S-8 0001140361-25-006800 333-285520 25699615 33 234824 1 1
2025-02-27 8-K 8-K 2.02,9.01 0001140361-25-006302 001-36829 25680199 34 292605 1 1
2025-02-27 10-K 10-K 0000950170-25-029002 001-36829 25678519 34 20708165 1 1
2025-02-27 4 FORM 4 0001140361-25-006272 9455
2025-02-25 4 FORM 4 0001140361-25-005847 6506
2025-02-25 4 FORM 4 0001140361-25-005846 4773
2025-02-25 4 FORM 4 0001140361-25-005845 4930
2025-02-25 4 FORM 4 0001140361-25-005844 6234
2025-02-25 144 xsl144X01/primary_doc.xml 0001959173-25-001325 001-36829 25660962 33 4602
2025-02-21 144 xsl144X01/primary_doc.xml 0001959173-25-001259 001-36829 25652371 33 5159
2025-02-21 144 xsl144X01/primary_doc.xml 0001959173-25-001254 001-36829 25652100 33 5191
2025-02-21 144 xsl144X01/primary_doc.xml 0001959173-25-001252 001-36829 25652015 33 5162
2025-02-21 144 xsl144X01/primary_doc.xml 0001959173-25-001251 001-36829 25651998 33 5219
2025-02-21 144 xsl144X01/primary_doc.xml 0001959173-25-001250 001-36829 25651939 33 5773
2025-02-13 4 FORM 4 0001140361-25-004297 7121
2025-02-13 4 FORM 4 0001140361-25-004296 8581
2025-02-13 4 FORM 4 0001140361-25-004295 7242
2025-02-13 4 FORM 4 0001140361-25-004294 8854
2025-02-13 4 FORM 4 0001140361-25-004293 7136
2025-02-13 4 FORM 4 0001140361-25-004292 7274
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000069 005-88750 25604188 34 17332
2025-02-05 4 FORM 4 0001140361-25-003241 7520
2025-02-05 3 FORM 3 0001140361-25-003239 11190
2025-01-31 144 xsl144X01/primary_doc.xml 0001959173-25-000573 001-36829 25577987 33 5197
2025-01-28 8-K 8-K 5.02 0001140361-25-002103 001-36829 25560699 34 164059 1 1
2025-01-27 4 FORM 4 0001140361-25-002069 4929
2025-01-23 144 xsl144X01/primary_doc.xml 0001959173-25-000445 001-36829 25549795 33 5772
2024-12-16 SC 13D/A SC 13D/A 0001193125-24-279899 005-88750 241553309 34 53086
2024-12-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020690 9441
2024-12-12 8-K FORM 8-K 1.01,8.01,9.01 0001140361-24-049137 001-36829 241544790 34 574408 1 1
2024-12-12 424B5 424B5 0001140361-24-049074 333-281606 241543114 33 730403 1 1
2024-12-10 424B5 424B5 0001140361-24-048911 333-281606 241538537 33 577416
2024-12-05 8-K 8-K 5.02 0001140361-24-048475 001-36829 241529248 34 158154 1 1
2024-11-25 4 FORM 4 0001140361-24-047757 4932
2024-11-25 4 FORM 4 0001140361-24-047756 6508
2024-11-25 4 FORM 4 0001140361-24-047755 6236
2024-11-25 4 FORM 4 0001140361-24-047754 4780
2024-11-21 144 xsl144X01/primary_doc.xml 0001959173-24-008064 001-36829 241484820 33 4579
2024-11-21 144 xsl144X01/primary_doc.xml 0001959173-24-008060 001-36829 241484281 33 5198
2024-11-21 144 xsl144X01/primary_doc.xml 0001959173-24-008056 001-36829 241484136 33 4580
2024-11-21 144 xsl144X01/primary_doc.xml 0001959173-24-008050 001-36829 241483910 33 4638
2024-11-18 8-K 8-K 7.01,8.01,9.01 0001140361-24-047166 001-36829 241471693 34 1865166 1 1
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000478 005-88750 241438636 34 36282
2024-11-07 10-Q 10-Q 0000950170-24-123459 001-36829 241436690 34 9091842 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001140361-24-045670 001-36829 241436126 34 288445 1 1
2024-11-04 4 FORM 4 0001140361-24-045101 4898
2024-11-04 4 FORM 4 0001140361-24-045099 4931
2024-10-31 144 xsl144X01/primary_doc.xml 0001959173-24-007293 001-36829 241414948 33 5202
2024-10-31 144 xsl144X01/primary_doc.xml 0001959173-24-007292 001-36829 241414899 33 4601
2024-10-29 4 FORM 4 0001140361-24-044548 5225
2024-10-29 4 FORM 4 0001140361-24-044546 7400
2024-09-11 4 FORM 4 0001140361-24-040838 7449
2024-09-11 8-K 8-K 5.02 0001140361-24-040837 001-36829 241292662 34 163249 1 1
2024-09-11 3 FORM 3 0001140361-24-040836 10396
2024-08-20 4 FORM 4 0001140361-24-037934 4783
2024-08-20 4 FORM 4 0001140361-24-037933 6321
2024-08-20 4 FORM 4 0001140361-24-037932 6048
2024-08-20 4 FORM 4 0001140361-24-037931 4593
2024-08-16 S-3ASR S-3ASR 0001140361-24-037673 333-281606 241216719 33 1226636 1 1
2024-08-16 144 xsl144X01/primary_doc.xml 0001959173-24-005709 001-36829 241216351 33 5775
2024-08-16 144 xsl144X01/primary_doc.xml 0001959173-24-005707 001-36829 241216316 33 5168
2024-08-16 144 xsl144X01/primary_doc.xml 0001959173-24-005705 001-36829 241216281 33 5163
2024-08-16 144 xsl144X01/primary_doc.xml 0001959173-24-005703 001-36829 241216251 33 5214
2024-08-06 10-Q 10-Q 0000950170-24-091838 001-36829 241179464 34 8789500 1 1
2024-08-05 8-K 8-K 2.02,9.01 0001140361-24-035756 001-36829 241175007 34 281229 1 1
2024-07-24 4 FORM 4 0001140361-24-034029 4782
2024-07-22 144 xsl144X01/primary_doc.xml 0001959173-24-005018 001-36829 241131357 33 5774
2024-07-09 4 FORM 4 0001140361-24-032761 4846
2024-07-08 144 xsl144X01/primary_doc.xml 0001959173-24-004801 001-36829 241104358 33 5184
2024-06-28 8-K 8-K 8.01,9.01 0001140361-24-031749 001-36829 241085653 34 197563 1 1
2024-06-20 4 FORM 4 0001140361-24-030729 7559
2024-06-20 4 FORM 4 0001140361-24-030731 7519
2024-06-20 4 FORM 4 0001140361-24-030728 5211
2024-06-20 4 FORM 4 0001140361-24-030727 5183
2024-06-20 4 FORM 4 0001140361-24-030730 5199
2024-06-20 4 FORM 4 0001140361-24-030726 5174
2024-06-20 4 FORM 4 0001140361-24-030725 7485
2024-06-20 4 FORM 4 0001140361-24-030724 7372
2024-06-20 4 FORM 4 0001140361-24-030723 5212
2024-06-20 8-K 8-K 5.03,5.07,9.01 0001140361-24-030718 001-36829 241056132 34 203533 1 1
2024-06-10 4/A FORM 4/A 0001140361-24-029438 6627
2024-05-20 4 FORM 4 0001140361-24-026884 6240
2024-05-20 4 FORM 4 0001140361-24-026881 4781
2024-05-20 4 FORM 4 0001140361-24-026878 21224
2024-05-20 4 FORM 4 0001140361-24-026873 16194
2024-05-20 4 FORM 4 0001140361-24-026871 25099
2024-05-16 144 xsl144X01/primary_doc.xml 0001959173-24-003644 001-36829 24956012 33 5224
2024-05-16 144 xsl144X01/primary_doc.xml 0001959173-24-003637 001-36829 24955202 33 5156
2024-05-16 144 xsl144X01/primary_doc.xml 0001959173-24-003635 001-36829 24955186 33 5747
2024-05-16 144 xsl144X01/primary_doc.xml 0001959173-24-003634 001-36829 24955184 33 6945
2024-05-07 10-Q 10-Q 0000950170-24-054465 001-36829 24921779 34 9840673 1 1
2024-05-06 8-K 8-K 2.02,9.01 0001140361-24-024574 001-36829 24918727 34 268723 1 1
2024-04-29 ARS ARS 0001140361-24-023048 001-36829 24891971 34 1689022
2024-04-29 DEFA14A DEFA14A 0001140361-24-023043 001-36829 24891928 34 965209
2024-04-29 DEF 14A DEF 14A 0001140361-24-023041 001-36829 24891910 34 5934550 1 1
2024-04-24 4 FORM 4 0001140361-24-021703 4780
2024-04-22 144 xsl144X01/primary_doc.xml 0001959173-24-003008 001-36829 24861004 33 6936
2024-04-17 PRE 14A PRE 14A 0001140361-24-020377 001-36829 24852080 34 6045906 1 1
2024-04-16 4 FORM 4 0001140361-24-020127 15820
2024-04-15 144 xsl144X01/primary_doc.xml 0001959173-24-002943 001-36829 24844835 33 5053
2024-04-12 144 xsl144X01/primary_doc.xml 0001959173-24-002926 001-36829 24841574 33 4466
2024-04-10 4 FORM 4 0001140361-24-019167 4846
2024-04-08 144 xsl144X01/primary_doc.xml 0001959173-24-002868 001-36829 24829358 33 4605
2024-04-05 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000295 005-88750 24824984 34 38020
2024-04-03 3 xslF345X02/form3.xml 0001140361-24-017686 30425
2024-04-03 4 FORM 4 0001140361-24-017684 7204
2024-04-03 3 FORM 3 0001140361-24-017681 10402
2024-03-29 8-K 8-K 5.02,9.01 0001140361-24-016666 001-36829 24804828 34 202683 1 1
2024-03-25 4 FORM 4 0001140361-24-015103 5166
2024-03-25 4 FORM 4 0001140361-24-015101 20018
2024-03-21 144 xsl144X01/primary_doc.xml 0001959173-24-002545 001-36829 24770090 33 6747
2024-03-04 4 FORM 4 0001140361-24-011170 8813
2024-03-04 4 FORM 4 0001140361-24-011168 4790
2024-02-29 144 xsl144X01/primary_doc.xml 0001959173-24-001588 001-36829 24703329 33 5010
2024-02-29 144 xsl144X01/primary_doc.xml 0001959173-24-001578 001-36829 24702953 33 5616
2024-02-27 10-K 10-K 0000950170-24-021096 001-36829 24686517 34 14276102 1 1
2024-02-26 8-K 8-K 2.02,9.01 0001140361-24-009506 001-36829 24679564 34 284183 1 1
2024-02-21 4 FORM 4 0001140361-24-008890 9481
2024-02-21 4 FORM 4 0001140361-24-008889 11272
2024-02-21 4 FORM 4 0001140361-24-008888 9639
2024-02-21 4 FORM 4 0001140361-24-008887 7273
2024-02-21 4 FORM 4 0001140361-24-008886 11019
2024-02-16 144/A xsl144X01/primary_doc.xml 0001959173-24-001136 001-36829 24649722 33 5313
2024-02-16 144 xsl144X01/primary_doc.xml 0001959173-24-001126 001-36829 24648997 33 5008
2024-02-16 144 xsl144X01/primary_doc.xml 0001959173-24-001123 001-36829 24648899 33 4429
2024-02-16 144 xsl144X01/primary_doc.xml 0001959173-24-001119 001-36829 24648802 33 5065
2024-02-16 144 xsl144X01/primary_doc.xml 0001959173-24-001116 001-36829 24648725 33 5622
2024-02-16 4 FORM 4 0001140361-24-008359 10661
2024-02-16 4 FORM 4 0001140361-24-008358 10931
2024-02-16 4 FORM 4 0001140361-24-008360 6983
2024-02-16 4 FORM 4 0001140361-24-008357 9376
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021855 005-88750 24629607 34 13164
2024-02-13 8-K 8-K 8.01,9.01 0001140361-24-007462 001-36829 24626735 34 194913 1 1
2024-02-08 SC 13G SEC SCHEDULE 13G 0000902219-24-000121 005-88750 24607334 34 38039
2024-01-29 SC 13G/A us77313f1066_012924.txt 0001086364-24-005099 005-88750 24573085 34 13822
2024-01-23 4 FORM 4 0001140361-24-003421 5252
2024-01-22 4 FORM 4 0001140361-24-003111 7156
2024-01-22 144 xsl144X01/primary_doc.xml 0001959173-24-000383 001-36829 24548513 33 5047
2024-01-22 SC 13G/A Rocket_Phar_Inc.txt 0000093751-24-000050 005-88750 24547585 34 8557
2023-12-13 8-K 8-K 5.02 0001140361-23-057478 001-36829 231484009 34 166390 1 1
2023-12-12 4 xslF345X05/form4.xml 0001140361-23-057390 7391
2023-12-12 3 xslF345X02/form3.xml 0001140361-23-057388 10351
2023-11-16 4 xslF345X05/form4.xml 0001140361-23-053713 5665
2023-11-16 4 xslF345X05/form4.xml 0001140361-23-053711 8611
2023-11-16 4 xslF345X05/form4.xml 0001140361-23-053709 8338
2023-11-16 4 FORM 4 0001140361-23-053705 7074
2023-11-16 144 xsl144X01/primary_doc.xml 0001959173-23-004817 001-36829 231414354 33 4980
2023-11-16 144 xsl144X01/primary_doc.xml 0001959173-23-004816 001-36829 231414337 33 4924
2023-11-16 144 xsl144X01/primary_doc.xml 0001959173-23-004815 001-36829 231414335 33 5545
2023-11-07 10-Q 10-Q 0000950170-23-060339 001-36829 231384580 34 11838617 1 1
2023-10-25 4 xslF345X05/form4.xml 0001140361-23-049426 5150
2023-10-20 4/A xslF345X05/form4.xml 0001140361-23-049079 9804
2023-10-20 144 xsl144X01/primary_doc.xml 0001959173-23-004381 001-36829 231337029 33 5538
2023-10-10 4 xslF345X05/form4.xml 0001140361-23-047589 8983
2023-10-02 4 xslF345X05/form4.xml 0001140361-23-046452 7285
2023-10-02 8-K 8-K 8.01,9.01 0001140361-23-046302 001-36829 231299636 34 196094 1 1
2023-09-20 424B5 424B5 0001140361-23-044609 333-253756 231266602 33 13252
2023-09-19 4 xslF345X05/ownership.xml 0000902664-23-004827 9205
2023-09-19 SC 13D/A ROCKET PHARMACEUTICALS, INC. 0000902664-23-004826 005-88750 231263913 34 57203
2023-09-15 8-K FORM 8-K 1.01,9.01 0001140361-23-044141 001-36829 231258613 34 716564 1 1
2023-09-13 424B5 424B5 0001140361-23-043843 333-253756 231253485 33 623334
2023-09-13 8-K 8-K 1.01,9.01 0001140361-23-043736 001-36829 231251526 34 187299 1 1
2023-09-12 424B5 424B5 0001140361-23-043709 333-253756 231250979 33 625027
2023-09-12 8-K FORM 8-K 7.01,8.01,9.01 0001140361-23-043687 001-36829 231250728 34 7584015 1 1
2023-08-30 4 xslF345X05/ownership.xml 0000902664-23-004651 19157
2023-08-21 4 xslF345X05/form4.xml 0001140361-23-040695 6311
2023-08-21 4 xslF345X05/form4.xml 0001140361-23-040694 6054
2023-08-21 4 xslF345X05/form4.xml 0001140361-23-040693 4717
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003348 001-36829 231181667 33 5546
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003346 001-36829 231181581 33 4925
2023-08-17 144 xsl144X01/primary_doc.xml 0001959173-23-003345 001-36829 231181579 33 4979
2023-08-15 4 xslF345X05/form4.xml 0001140361-23-039905 7054
2023-08-15 4 xslF345X05/form4.xml 0001140361-23-039904 8613
2023-08-15 4 xslF345X05/form4.xml 0001140361-23-039901 8356
2023-08-09 10-Q 10-Q 0001140361-23-038855 001-36829 231156332 34 9477778 1 1
2023-07-24 4 xslF345X05/form4.xml 0001140361-23-035859 4717
2023-07-20 4 xslF345X05/form4.xml 0001140361-23-035428 7055

Latest XBRL company facts

One latest value per concept from companyfacts (353 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 111.66M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
dei EntityPublicFloat Entity Public Float USD 212.50M 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076551
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.37M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.48M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 0 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -327,596 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.51M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 17.94 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
ffd NetFeeAmt NetFeeAmt USD 3,553.84 2026-07-14 S-8 2026-07-14 0001140361-26-028436
ffd TtlFeeAmt TtlFeeAmt USD 3,553.84 2026-07-14 S-8 2026-07-14 0001140361-26-028436
ffd TtlOfferingAmt TtlOfferingAmt USD 25.73M 2026-07-14 S-8 2026-07-14 0001140361-26-028436
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-14 S-8 2026-07-14 0001140361-26-028436
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-27 SC TO-I 2026-04-27 0001140361-26-016865
ffd TtlTxValtn TtlTxValtn USD 5.57M 2026-04-27 SC TO-I 2026-04-27 0001140361-26-016865
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 35.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 66,000 2018-06-30 2018 Q2 10-Q 2018-08-14 0001140361-18-036347
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 790,000 2020-03-31 2020 Q1 10-Q 2020-05-08 0001140361-20-011097
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap AccruedExchangeFeeRebateCurrent Accrued Exchange Fee Rebate, Current USD 283,000 2020-03-31 2020 Q1 10-Q 2020-05-08 0001140361-20-011097
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 8.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.37M 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AccruedRentCurrentAndNoncurrent Accrued Rent USD 5,000 2015-09-30 2015 Q3 10-Q 2015-11-12 0001193125-15-374713
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 275,000 2020-03-31 2020 Q1 10-Q 2020-05-08 0001140361-20-011097
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 33.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -393,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.74B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 316.09M 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 16,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD -131,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.35M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 9.30M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 12.78M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 17.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 437,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap Assets Assets USD 419.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AssetsCurrent Assets, Current USD 278.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 127,000 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 101.90M 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 11.56M 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 11.55M 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 174.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 101.78M 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 10,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 16,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 75,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342348
us-gaap Cash Cash USD 286.90M 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091838
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 95.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 153.00M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 279.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 96.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 17.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 24.82 2020-09-30 2020 Q3 10-Q 2020-11-06 0001140361-20-024856
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 7,051 2021-03-31 2021 Q1 10-Q 2021-05-10 0001140361-21-016643
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 180.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 111.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 111.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonStockValue Common Stock, Value, Issued USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap CommonUnitIssued Common Unit, Issued shares 16.33M 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-188339
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 26.93M 2016-06-30 2016 Q2 10-Q 2016-08-10 0001193125-16-677550
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 26.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -29.46M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap ConstructionPayableCurrent Construction Payable, Current USD 185,000 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap CostOfGoodsAndServicesSoldDepreciation Cost, Depreciation USD 3.55M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060339
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 35.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 12.07M 2015-06-30 2015 Q2 10-Q 2015-08-07 0001193125-15-281532
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 4.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.62M 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 457,000 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 1.67M 2014-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 9.52M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 78.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 127.13M 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 83.43M 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.19M 2020-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 24.98M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 133.09M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 5.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 5.96M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 481,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap Depreciation Depreciation USD 200,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0001140361-20-017582
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -42.79M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 480,000 2014-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 8.57M 2015-06-30 2015 Q2 10-Q 2015-08-07 0001193125-15-281532
us-gaap DirectCostsOfLeasedAndRentedPropertyOrEquipment Direct Costs of Leased and Rented Property or Equipment USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.52 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.125 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 8.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.002 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 9.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 45.60M 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4.62M 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -4.40M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 1.67M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060339
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 21.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 19.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 45.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 36.76M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 2.09M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 485,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 24.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 38.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -4.24M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 54.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap Goodwill Goodwill USD 39.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 8.34M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap GovernmentContractReceivableProgessPaymentsOffset Government Contract Receivable, Progress Payment Offset USD 0 2020-03-31 2020 Q1 10-Q 2020-05-08 0001140361-20-011097
us-gaap GrantsReceivable Grants Receivable USD 1.10M 2020-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 600,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 35.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 8.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 6.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -46.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -523,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.14M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.05M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342348
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.85M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 393,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 120,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060339
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 69,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342348
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 266,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 1.97M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211873
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-04 0001140361-22-040004
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 14.16M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211873
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 25.15M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap InterestExpense Interest Expense USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.96M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap InventoryNet Inventory, Net USD 393,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001140361-19-008828
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.26M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001140361-18-042845
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap LeaseCost Lease, Cost USD 3.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.32M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 872,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 557,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 557,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 627,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 638,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 257,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 926,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap Liabilities Liabilities USD 92.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 419.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LiabilitiesCurrent Liabilities, Current USD 38.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebt Long-term Debt USD 30.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 19.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 15.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermInvestments Long-term Investments USD 9.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 2.55M 2014-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001140361-22-028904
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 34.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 19,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 107.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 75.02M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -124.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -26.11M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 26.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 26.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 445,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.48M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap NotesPayableToBankCurrent Notes Payable to Bank, Current USD 3.06M 2014-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingExpenses Operating Expenses USD 146.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -146.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseCost Operating Lease, Cost USD 682,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 262,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 959,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeasePayments Operating Lease, Payments USD 766,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.60M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-04 0001140361-22-040004
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 31.47M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.74M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.78M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.80M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.25M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.53M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 20.36M 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 788,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001140361-19-020183
us-gaap OperatingLeasesIncomeStatementSubleaseRevenue Operating Leases, Income Statement, Sublease Revenue USD 300,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001140361-20-005056
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 300,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001140361-21-016643
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.089 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 168,000 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -362,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 4.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 69,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap OtherNoncashExpense Other Noncash Expense USD 274,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-188339
us-gaap OtherOperatingIncome Other Operating Income USD 15,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -28,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001140361-18-042845
us-gaap OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held USD 0 2018-09-30 2018 Q3 10-Q 2018-11-09 0001140361-18-042845
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap PaymentsForRestructuring Payments for Restructuring USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 236.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 70,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 252,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 27.20M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap PaymentsToAcquireSoftware Payments to Acquire Software USD 748,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001140361-21-036826
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 131,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 8.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 18.90M 2015-01-01 2015-03-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 38.09M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091838
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001140361-18-042845
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 33.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 188.88M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060339
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 63,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 4.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 166.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 180.00M 2026-04-01 2026-04-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap ProceedsFromSaleOfTreasuryStock Proceeds from Sale of Treasury Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 57.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 23.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap RegulatoryLiabilityCurrent Regulatory Liability, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 5.80M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-08 0001140361-19-004603
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 92.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RestrictedCashEquivalentsNoncurrent Restricted Cash Equivalents, Noncurrent USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employees 70 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.3 2025-07-01 2025-07-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RestructuringReserve Restructuring Reserve USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.41B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001140361-18-023041
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 7,051 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.932 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.739 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001140361-26-013335
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 730,500 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 13.37 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022495
us-gaap ShortTermInvestments Short-term Investments USD 174.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 326.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.835 2015-01-01 2015-01-31 2016 FY 10-K 2017-03-16 0001564590-17-004532
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 40.69M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 35,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 182.53M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 61,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 56,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 72,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001140361-23-009252
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 72,000 2020-01-01 2020-03-31 2020 Q2 10-Q 2020-08-05 0001140361-20-017582
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -131,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 46.80M 2014-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 28.66M 2014-12-31 2015 Q3 10-Q 2015-11-12 0001193125-15-374713
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021096
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0001140361-22-007036
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 0 2019-01-01 2019-03-31 2020 Q3 10-Q 2020-11-06 0001140361-20-024856
us-gaap TreasuryStockShares Treasury Stock, Shares shares 2,571 2023-03-31 2023 Q1 10-Q 2023-05-05 0001140361-23-023233
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 100,000 2018-12-27 2018-12-28 2019 Q3 10-Q 2019-11-08 0001140361-19-020183
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 100,000 2019-01-01 2019-01-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap TreasuryStockValue Treasury Stock, Value USD 47,000 2023-03-31 2023 Q1 10-Q 2023-05-05 0001140361-23-023233
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 47,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap TreasuryStockValueAcquiredParValueMethod Treasury Stock, Value, Acquired, Par Value Method USD 727,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-08 0001140361-20-011097
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -362,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 4,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076551
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 51,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 6,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-07 0001564590-18-004621
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001193125-16-514228
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 20.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029002
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 114.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 55.38M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001140361-21-006677
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 112.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458320

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →